SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-19-000336
Filing Date
2019-09-27
Accepted
2019-09-26 20:41:20
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDING JUNE 30, 2019 bivi-20190630_10k.htm 10-K 706809
2 EXHIBIT 4.4 bivi-20190630_10kex4z4.htm EX-4.4 17641
3 EXHIBIT 31.1 bivi-20190630_10kex31z1.htm EX-31.1 14563
4 EXHIBIT 31.2 bivi-20190630_10kex31z2.htm EX-31.2 14419
5 EXHIBIT 32.1 bivi-20190630_10kex32z1.htm EX-32.1 5302
6 EXHIBIT 32.2 bivi-20190630_10kex32z2.htm EX-32.2 5523
7 GRAPHIC image_001.jpg GRAPHIC 28096
  Complete submission text file 0001520138-19-000336.txt   2626239

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE bivi-20190630.xml EX-101.INS 331424
9 XBRL CALCULATION FILE bivi-20190630_cal.xml EX-101.CAL 34454
10 XBRL DEFINITION FILE bivi-20190630_def.xml EX-101.DEF 70209
11 XBRL LABEL FILE bivi-20190630_lab.xml EX-101.LAB 235497
12 XBRL PRESENTATION FILE bivi-20190630_pre.xml EX-101.PRE 165632
13 XBRL SCHEMA FILE bivi-20190630.xsd EX-101.SCH 27533
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39015 | Film No.: 191119372
SIC: 2834 Pharmaceutical Preparations